Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05
Published September 2, 2020 · Recall initiated: July 22, 2020
Summary
FDA records drug Class I recall D-1537-2020, published September 2, 2020 and initiated July 22, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 25,100 bottles; Lot: Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with other products: trace amounts of lidocaine
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by FreseniusSeptember 2, 2026
- FDAMorphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular orAugust 26, 2026
- FDAGlycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only,July 29, 2026
- FDAXylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL,July 29, 2026
- FDASulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, RxSeptember 2, 2020
- FDAHand Sanitizer (Alcohol 80% v/v) topical solution, 55 US GAL (208 L) EcoLab Inc 1 EcoLab Place St. Paul, MNSeptember 2, 2020
Questions about this recall
Was Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05 recalled?
Yes. FDA published recall D-1537-2020 on September 2, 2020. Reported hazard: Cross Contamination with other products: trace amounts of lidocaine
What should I do if I have this product?
Voluntary: Firm initiated · Press Release